Advancing Safety Assessment of ADCs: Assessing Opportunities & Challenges in In Vitro Model Applications

• Overviewing ADC toxicities and general strategy at the discovery toxicology stage
• Exploring examples of applications of advanced in vitro models to complement ADC safety analysis alongside in vivo tools
• Understanding key gaps and challenges to overcome for in vitro ADC safety assessments

Speakers:

Barbara Musial

Senior Scientist, Oncology Safety

AstraZeneca